After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

Leaked Pfizer Phase 1 trial shows mevrometostat plus Xtandi reduced prostate cancer progression risk by 49%. Data sparked ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

The shattered family of one year-old Myles Love knew something was not right with their pale and poorly baby - but medics ...

The global chemical maker Bayer is backing an expanded effort to shield itself from lawsuits alleging its popular weedkiller ...

The American Association for Cancer Research Annual Meeting 2025 will be held from April 25-30 in Chicago, Illinois, providing a ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.

People are also enquiring whether cancer will be a disease of the past like polio or measles after the vaccine is available ...

Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...